Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Www.fda.gov save search
FDA Roundup: December 5, 2023
Published: 2023-12-05 (Crawled : 14:30) - fda.gov
LLY 6 d | $588.27 -0.17% -0.1% 2.1M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
fda
FDA Roundup: November 14, 2023
Published: 2023-11-14 (Crawled : 21:00) - fda.gov
BDX | News | $233.54 0.45% 0.0% 2.2M
|
Health Technology
|
| O: -1.42%
H: 0.0%
C: 0.0%
AMZN | $146.8 1.56% 1.53% 50M
|
Retail Trade
|
| O: 1.42%
H: 0.16%
C: -2.62%
fda
FDA Roundup: November 7, 2023
Published: 2023-11-07 (Crawled : 21:00) - fda.gov
TNDM | $24.01 8.01% 7.41% 2.1M
|
Health Technology
|
| O: -2.58%
H: 0.0%
C: 0.0%
fda
FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants
Published: 2023-10-26 (Crawled : 15:30) - fda.gov
ABT | News | $104.05 -0.85% -0.14% 5.2M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
fda
FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes
Published: 2023-10-24 (Crawled : 20:00) - fda.gov
ABT | News | $104.05 -0.85% -0.14% 5.2M
|
Health Technology
|
| O: -0.89%
H: 0.09%
C: -1.04%
fda rare blood therapy
FDA Roundup: October 17, 2023
Published: 2023-10-17 (Crawled : 21:00) - fda.gov
BMY | News P | $50.16 0.56% 0.0% 14M
|
Health Technology
|
| O: 0.17%
H: 0.33%
C: -0.96%
fda
FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products
Published: 2023-09-12 (Crawled : 15:30) - fda.gov
WBA | $22.905 7.13% 6.66% 27M
|
Retail Trade
|
| O: 0.51%
H: 3.39%
C: 0.84%
fda eye
FDA Roundup: August 15, 2023
Published: 2023-08-15 (Crawled : 20:00) - fda.gov
FNCTF | News | $11.85 -22.84% 400
|
Communications
|
| O: 1.51%
H: 0.0%
C: -1.03%
PFE A | $28.63 -0.56% 0.0% 35M
|
Health Technology
|
| O: -2.01%
H: 1.45%
C: 0.97%
fda
La FDA aprueba el primer tratamiento oral para la depresión posparto
Published: 2023-08-08 (Crawled : 14:00) - fda.gov
SAGE | $20.86 0.05% 0.05% 620K
|
Health Technology
|
| O: -12.79%
H: 14.24%
C: 13.35%
fda
FDA Approves First Oral Treatment for Postpartum Depression
Published: 2023-08-04 (Crawled : 23:00) - fda.gov
SAGE | $20.86 0.05% 0.05% 620K
|
Health Technology
| Email alert
Add to watchlist
fda depression treatment
FDA Roundup: July 21, 2023
Published: 2023-07-21 (Crawled : 20:00) - fda.gov
JNJ | News | $155.4 -0.78% -0.02% 6.4M
|
Health Technology
| Email alert
Add to watchlist
fda
FDA Approves First Nonprescription Daily Oral Contraceptive
Published: 2023-07-13 (Crawled : 13:00) - fda.gov
PRGO | News | $30.55 3.14% 0.0% 4.1M
|
Health Technology
|
| O: 5.77%
H: 0.0%
C: -5.0%
fda contraceptive
FDA Approves First Gene Therapy for Adults with Severe Hemophilia A
Published: 2023-06-29 (Crawled : 22:00) - fda.gov
BMRN A | $94.93 0.82% 0.81% 2.5M
|
Health Technology
|
| O: 1.2%
H: 1.97%
C: -3.69%
fda therapy
FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy
Published: 2023-06-22 (Crawled : 18:00) - fda.gov
SRPT F | $88.4 1.17% 1.15% 690K
|
Health Technology
|
| O: -3.2%
H: 0.03%
C: -4.89%
fda treatment duchenne therapy
FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process
Published: 2023-06-06 (Crawled : 19:00) - fda.gov
HLTH | $0.341 3.65% 3.52% 190K
|
|
| O: -0.96%
H: 0.15%
C: -9.39%
covid-19 fda test review
FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation
Published: 2023-04-17 (Crawled : 18:00) - fda.gov
GMDA | $0.325 2.3% 2.25% 1.7M
|
Health Technology
|
| O: 2.85%
H: 68.67%
C: 34.94%
fda infection cell blood risk therapy
FDA Roundup: March 21, 2023
Published: 2023-03-21 (Crawled : 20:00) - fda.gov
INSP | $160.9 6.04% 2.0% 1.1M
|
Health Technology
|
| O: -0.69%
H: 1.23%
C: -1.98%
fda
FDA Roundup: September 23, 2022
Published: 2022-09-23 (Crawled : 20:00) - fda.gov
LLY 6 d | $588.27 -0.17% -0.1% 2.1M
|
Health Technology
| Email alert
Add to watchlist
fda
FDA Roundup: September 13, 2022
Published: 2022-09-13 (Crawled : 19:00) - fda.gov
NVAX | $5.52 -1.08% -1.09% 5.3M
|
Health Technology
|
| O: 1.2%
H: 5.65%
C: 4.49%
fda
FDA Roundup: September 2, 2022
Published: 2022-09-02 (Crawled : 18:00) - fda.gov
AMLX | $14.21 -5.83% -6.19% 1.8M
|
|
| O: 1.83%
H: 0.0%
C: -24.57%
fda
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
SLDB | News M | $5.89 72.22% 41.94% 12M
|
Health Technology
SVFD | News | $3.09 43.72% 30.42% 64M
|
FTEL | $2.04 43.66% 30.39% 110K
|
HPCO 4 | $0.4824 41.92% 29.54% 28M
|
ALGS | News | $0.6475 -5.06% 26.67% 2.1M
|
Health Technology
GTHX | $3.16 30.58% 23.42% 10M
|
Health Technology
KEQU | $22.5 27.62% 21.64% 24K
|
Producer Manufacturing
GSIT | $3.09 27.16% 21.36% 2.2M
|
Electronic Technology
SSKN P | $0.628 25.6% 20.38% 210K
|
Health Technology
GLUE | $3.66 22.82% 18.58% 510K
|
Professional, Scientific, and T...
Your saved searches
Save your searches and get alerts when important news are released.